Summit Corp PLC (SUMM)

Back to homepage

Company Description

Summit Corp PLC was incorporated on August 4, 2004.The Company is a drug discovery and development company to treat areas of unmet medical need. The Company's current therapeutic focuses the rare disease Duchenne Muscular Dystrophy (DMD) and the infectious disease caused by the bacteria C.difficile. The Drug Development segment covers Summit's research and development activities carried out by the Group, primarily comprising the DMD and the CDI programmes. The Company has operations in the United Kingdom, USA and Europe...